24096-52-4

Basic information

• Product Name: 1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE
• Synonyms: TIMTEC-BB SBB000818;N-(3,5-DICHLOROPHENYL)MALEIMIDE;1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE;1-(3,5-DICHLORPHENYL)-1H-PYRROLE-2,5-DIONE;AKOS MSC-0045;ASISCHEM C66331;1-(3,5-dichlorophenyl)-3-pyrroline-2,5-quinone;1-(3,5-Dichlorophenyl)-1H-pyrrole-2,5-dione
• CAS NO: 24096-52-4
• Molecular Formula: C₁₀H₅Cl₂NO₂
• Molecular Weight: 242.06
• Mol File: 24096-52-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 396.2 °C at 760 mmHg
• Flash Point: 193.4 °C
• Appearance: /
• Density: 1.57 g/cm³
• Vapor Pressure: 1.74E-06mmHg at 25°C
• Refractive Index: 1.648
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE(24096-52-4)
• EPA Substance Registry System: 1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE(24096-52-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 24096-52-4(Hazardous Substances Data)

Usage

General Description

1-(3,5-Dichloro-phenyl)-pyrrole-2,5-dione is a chemical compound with the molecular formula C8H4Cl2NO2. It is a derivative of pyrrole-2,5-dione and contains two chlorine atoms attached to the phenyl ring. 1-(3,5-DICHLORO-PHENYL)-PYRROLE-2,5-DIONE has potential applications in the field of organic synthesis and material science. It may also possess biological activity and could be of interest in pharmaceutical research. Additionally, its unique structure and properties make it a valuable building block for the development of new compounds with diverse functionalities. Further research and exploration of the chemical and its potential applications are warranted to fully understand its properties and potential uses.

InChI:InChI=1/C10H5Cl2NO2/c11-6-3-7(12)5-8(4-6)13-9(14)1-2-10(13)15/h1-5H

Upstream product

• 617-48-1 malic acid 
• 626-43-7 3,5-Dichloroaniline 
• 55198-61-3 (Z)-4-((3,5-dichlorophenyl)amino)-4-oxobut-2-enoic acid 
• 108-31-6 maleic anhydride 

Downstream Products

• 144835-83-6 3-phenyl-5-(3,5-dichlorophenyl)-3a,4,6,6a-tetrahydropyrrolo<3,4-d>isoxazole 
• 144835-87-0 (3aR,6aS)-5-(3,5-Dichloro-phenyl)-3-(3-nitro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-99-4 (3aR,6aS)-3-(4-Bromo-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-92-7 (3aR,6aS)-3-(3-Chloro-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-94-9 (3aR,6aS)-3-(2,4-Dichloro-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-86-9 (3aS,6aR)-5-(3,5-Dichloro-phenyl)-3-(2-nitro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-96-1 (3aS,6aR)-3-(3,4-Dichloro-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 117954-68-4 N-(3,5-dichlorophenyl)-2-cysteinylsuccimide methyl ester hydrochloride 
• 144835-90-5 (3aR,6aS)-5-(3,5-Dichloro-phenyl)-3-(4-fluoro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-91-6 (3aR,6aS)-3-(2-Chloro-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-89-2 (3aR,6aS)-5-(3,5-Dichloro-phenyl)-3-(2-fluoro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-97-2 (3aR,6aS)-3-(2-Bromo-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-98-3 (3aR,6aS)-3-(3-Bromo-phenyl)-5-(3,5-dichloro-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 
• 144835-48-3 (3aS,6aR)-5-(3,5-Dichloro-phenyl)-3-(2-trifluoromethyl-phenyl)-3a,6a-dihydro-pyrrolo[3,4-d]isoxazole-4,6-dione 

Relevant articles and documents

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

The invention relates to a compound of Formula (I) or (IA) compositions comprising compounds of Formula (I) or (IA), and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula (I) or (IA) to a patient in need thereof:

SMALL MOLECULE LFA-1 INHIBITORS

The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.

Direct synthesis of imides from dicarboxylic acids using microwaves

1,4- and 1,5-dicarboxylic acids, when treated with amines in a domestic microwave oven, afford good yields of the corresponding imides.